vs
Pure Storage, Inc.（PSTG）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Pure Storage, Inc.的季度营收约是Royalty Pharma plc的1.6倍（$964.5M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 5.7%，领先28.8%），Pure Storage, Inc.同比增速更快（16.0% vs 4.8%），过去两年Pure Storage, Inc.的营收复合增速更高（10.5% vs 4.6%）
Pure Storage是美国上市科技企业，总部位于加利福尼亚州圣克拉拉，成立于2009年，2011年正式推出自研全闪存数据存储软硬件产品，2015年上市前累计获得超4.7亿美元风险投资，营收长期保持高速增长态势。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
PSTG vs RPRX — 直观对比
营收规模更大
PSTG
是对方的1.6倍
$622.0M
营收增速更快
PSTG
高出11.3%
4.8%
净利率更高
RPRX
高出28.8%
5.7%
两年增速更快
PSTG
近两年复合增速
4.6%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $964.5M | $622.0M |
| 净利润 | $54.8M | $214.2M |
| 毛利率 | 72.3% | — |
| 营业利润率 | 5.6% | 62.4% |
| 净利率 | 5.7% | 34.4% |
| 营收同比 | 16.0% | 4.8% |
| 净利润同比 | -13.9% | 2.9% |
| 每股收益（稀释后） | $0.16 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PSTGRPRX
| Q4 25 | $964.5M | $622.0M | ||
| Q3 25 | $861.0M | $609.3M | ||
| Q2 25 | $778.5M | $578.7M | ||
| Q1 25 | $879.8M | $568.2M | ||
| Q4 24 | $831.1M | $593.6M | ||
| Q3 24 | $763.8M | $564.7M | ||
| Q2 24 | $693.5M | $537.3M | ||
| Q1 24 | $789.8M | $568.0M |
净利润PSTGRPRX
| Q4 25 | $54.8M | $214.2M | ||
| Q3 25 | $47.1M | $288.2M | ||
| Q2 25 | $-14.0M | $30.2M | ||
| Q1 25 | $42.4M | $238.3M | ||
| Q4 24 | $63.6M | $208.2M | ||
| Q3 24 | $35.7M | $544.0M | ||
| Q2 24 | $-35.0M | $102.0M | ||
| Q1 24 | $65.4M | $4.8M |
毛利率PSTGRPRX
| Q4 25 | 72.3% | — | ||
| Q3 25 | 70.2% | — | ||
| Q2 25 | 68.9% | — | ||
| Q1 25 | 67.5% | — | ||
| Q4 24 | 70.1% | — | ||
| Q3 24 | 70.7% | — | ||
| Q2 24 | 71.5% | — | ||
| Q1 24 | 72.0% | — |
营业利润率PSTGRPRX
| Q4 25 | 5.6% | 62.4% | ||
| Q3 25 | 0.6% | 70.1% | ||
| Q2 25 | -4.0% | 36.3% | ||
| Q1 25 | 4.8% | 94.0% | ||
| Q4 24 | 7.2% | 60.9% | ||
| Q3 24 | 3.3% | — | ||
| Q2 24 | -6.0% | 50.2% | ||
| Q1 24 | 7.3% | -13.0% |
净利率PSTGRPRX
| Q4 25 | 5.7% | 34.4% | ||
| Q3 25 | 5.5% | 47.3% | ||
| Q2 25 | -1.8% | 5.2% | ||
| Q1 25 | 4.8% | 41.9% | ||
| Q4 24 | 7.7% | 35.1% | ||
| Q3 24 | 4.7% | 96.3% | ||
| Q2 24 | -5.0% | 19.0% | ||
| Q1 24 | 8.3% | 0.8% |
每股收益（稀释后）PSTGRPRX
| Q4 25 | $0.16 | $0.49 | ||
| Q3 25 | $0.14 | $0.67 | ||
| Q2 25 | $-0.04 | $0.07 | ||
| Q1 25 | $0.13 | $0.55 | ||
| Q4 24 | $0.19 | $0.46 | ||
| Q3 24 | $0.10 | $1.21 | ||
| Q2 24 | $-0.11 | $0.23 | ||
| Q1 24 | $0.22 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $852.8M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $1.4B | $9.7B |
| 总资产 | $4.2B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资PSTGRPRX
| Q4 25 | $852.8M | $618.7M | ||
| Q3 25 | $887.8M | $938.9M | ||
| Q2 25 | $739.3M | $631.9M | ||
| Q1 25 | $723.6M | $1.1B | ||
| Q4 24 | $894.6M | $929.0M | ||
| Q3 24 | $965.0M | $950.1M | ||
| Q2 24 | $900.6M | $1.8B | ||
| Q1 24 | $702.5M | $843.0M |
总债务PSTGRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益PSTGRPRX
| Q4 25 | $1.4B | $9.7B | ||
| Q3 25 | $1.3B | $9.6B | ||
| Q2 25 | $1.2B | $9.5B | ||
| Q1 25 | $1.3B | $9.8B | ||
| Q4 24 | $1.4B | $10.3B | ||
| Q3 24 | $1.5B | $10.3B | ||
| Q2 24 | $1.4B | $9.8B | ||
| Q1 24 | $1.3B | $9.9B |
总资产PSTGRPRX
| Q4 25 | $4.2B | $19.6B | ||
| Q3 25 | $4.0B | $19.3B | ||
| Q2 25 | $3.8B | $18.3B | ||
| Q1 25 | $4.0B | $17.6B | ||
| Q4 24 | $3.9B | $18.2B | ||
| Q3 24 | $3.8B | $18.0B | ||
| Q2 24 | $3.6B | $17.7B | ||
| Q1 24 | $3.7B | $16.1B |
负债/权益比PSTGRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $116.0M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $52.6M | — |
| 自由现金流率自由现金流/营收 | 5.5% | — |
| 资本支出强度资本支出/营收 | 6.6% | — |
| 现金转化率经营现金流/净利润 | 2.12× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $566.7M | — |
8季度趋势，按日历期对齐
经营现金流PSTGRPRX
| Q4 25 | $116.0M | $827.1M | ||
| Q3 25 | $212.2M | $702.6M | ||
| Q2 25 | $283.9M | $364.0M | ||
| Q1 25 | $208.5M | $596.1M | ||
| Q4 24 | $97.0M | $742.5M | ||
| Q3 24 | $226.6M | $703.6M | ||
| Q2 24 | $221.5M | $658.2M | ||
| Q1 24 | $244.4M | $664.6M |
自由现金流PSTGRPRX
| Q4 25 | $52.6M | — | ||
| Q3 25 | $150.1M | — | ||
| Q2 25 | $211.6M | — | ||
| Q1 25 | $152.4M | — | ||
| Q4 24 | $35.2M | — | ||
| Q3 24 | $166.6M | — | ||
| Q2 24 | $172.7M | — | ||
| Q1 24 | $200.9M | — |
自由现金流率PSTGRPRX
| Q4 25 | 5.5% | — | ||
| Q3 25 | 17.4% | — | ||
| Q2 25 | 27.2% | — | ||
| Q1 25 | 17.3% | — | ||
| Q4 24 | 4.2% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | 24.9% | — | ||
| Q1 24 | 25.4% | — |
资本支出强度PSTGRPRX
| Q4 25 | 6.6% | — | ||
| Q3 25 | 7.2% | — | ||
| Q2 25 | 9.3% | — | ||
| Q1 25 | 6.4% | — | ||
| Q4 24 | 7.4% | — | ||
| Q3 24 | 7.9% | — | ||
| Q2 24 | 7.0% | — | ||
| Q1 24 | 5.5% | — |
现金转化率PSTGRPRX
| Q4 25 | 2.12× | 3.86× | ||
| Q3 25 | 4.50× | 2.44× | ||
| Q2 25 | — | 12.06× | ||
| Q1 25 | 4.91× | 2.50× | ||
| Q4 24 | 1.52× | 3.57× | ||
| Q3 24 | 6.35× | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | 3.74× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PSTG
| US | $683.2M | 71% |
| Non Us | $281.3M | 29% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
